|Day Low/High||18.68 / 19.12|
|52 Wk Low/High||8.74 / 18.83|
Company provides best in class arrhythmia detection in a patch form factor
Conditions are still overbought, staying stubbornly sticky to the upside.
Keep in mind that strong action like this tends to create underlying support.
Despite the S&P 500 reaching an all-time high, there is some hesitancy to keep chasing.
The Friday action was so surprising that many were poorly positioned -- and they are still scrambling to reposition.
We have chronically underinvested bulls, nervous bears and algos.
The problem for the bears is that there are still plenty of folks trying to extract some gains from the upside.
I can't seem to put enough capital to work in individual stocks.
It's a big move today, but the recent pattern doesn't inspire hope for it to last.
We are back to the old pattern of squeezing shorts and frustrating underinvested longs.
Investors considering a purchase of BioTelemetry, Inc. stock, but tentative about paying the going market price of $15.71/share, might benefit from considering selling puts among the alternative strategies at their disposal.
The only strategy that this market seems to recognize is buying the dips.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioTelemetry, Inc. , where a total of 785 contracts have traded so far, representing approximately 78,500 underlying shares.
The market may actually have a dip at some point, but the bulls will jump on any pullbacks.